USD 0.35
(-0.14%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 4.78 Million USD | 38.74% |
2022 | 3.45 Million USD | 9.68% |
2021 | 3.14 Million USD | -4.41% |
2020 | 3.29 Million USD | -5.23% |
2019 | 3.47 Million USD | 8.48% |
2018 | 3.2 Million USD | 3.53% |
2017 | 3.09 Million USD | 566.39% |
2016 | 464.21 Thousand USD | 141.94% |
2015 | 191.87 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 4.87 Million USD | 1.72% |
2024 Q2 | 4.32 Million USD | -11.24% |
2023 FY | 4.78 Million USD | 38.74% |
2023 Q1 | 4.29 Million USD | 24.56% |
2023 Q4 | 4.78 Million USD | -19.65% |
2023 Q2 | 4.79 Million USD | 11.63% |
2023 Q3 | 5.96 Million USD | 24.19% |
2022 Q3 | 3.98 Million USD | 10.77% |
2022 FY | 3.45 Million USD | 9.68% |
2022 Q1 | 4 Million USD | 27.35% |
2022 Q2 | 3.59 Million USD | -10.28% |
2022 Q4 | 3.45 Million USD | -13.34% |
2021 Q1 | 3.41 Million USD | 3.78% |
2021 FY | 3.14 Million USD | -4.41% |
2021 Q2 | 3.53 Million USD | 3.33% |
2021 Q3 | 3.59 Million USD | 1.79% |
2021 Q4 | 3.14 Million USD | -12.43% |
2020 Q1 | 3.41 Million USD | -1.71% |
2020 FY | 3.29 Million USD | -5.23% |
2020 Q2 | 3.68 Million USD | 8.04% |
2020 Q3 | 4.2 Million USD | 13.91% |
2020 Q4 | 3.29 Million USD | -21.65% |
2019 Q4 | 3.47 Million USD | -0.16% |
2019 FY | 3.47 Million USD | 8.48% |
2019 Q1 | 2.75 Million USD | -14.12% |
2019 Q2 | 3.62 Million USD | 31.75% |
2019 Q3 | 3.47 Million USD | -3.98% |
2018 Q1 | 2.07 Million USD | -33.02% |
2018 Q4 | 3.2 Million USD | 32.0% |
2018 Q3 | 2.42 Million USD | 16.88% |
2018 Q2 | 2.07 Million USD | 0.19% |
2018 FY | 3.2 Million USD | 3.53% |
2017 FY | 3.09 Million USD | 566.39% |
2017 Q4 | 3.09 Million USD | 47.53% |
2017 Q3 | 2.09 Million USD | 53.11% |
2017 Q2 | 1.36 Million USD | 270.28% |
2017 Q1 | 369.83 Thousand USD | -20.33% |
2016 Q4 | 464.21 Thousand USD | 21.74% |
2016 FY | 464.21 Thousand USD | 141.94% |
2016 Q3 | 381.3 Thousand USD | 133.75% |
2016 Q2 | 163.12 Thousand USD | -9.47% |
2016 Q1 | 180.19 Thousand USD | -6.09% |
2015 Q1 | - USD | 0.0% |
2015 FY | 191.87 Thousand USD | 0.0% |
2015 Q4 | 191.87 Thousand USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | -100.0% |
2014 Q3 | 39.77 Thousand USD | 21.64% |
2014 Q2 | 32.69 Thousand USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Safety Shot Inc | 1.86 Million USD | -156.147% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 96.851% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 95.693% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 29.25% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 85.188% |
Dynavax Technologies Corporation | 53.29 Million USD | 91.013% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 92.702% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 58.882% |
Pacira BioSciences, Inc. | 104.35 Million USD | 95.411% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 16.491% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 16.491% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -491.419% |
Journey Medical Corporation | 10.2 Million USD | 53.076% |
Alpha Teknova, Inc. | 11.59 Million USD | 58.694% |
Procaps Group, S.A. | 96.83 Million USD | 95.054% |
Theratechnologies Inc. | 6.06 Million USD | 21.051% |
Harrow Health, Inc. | 10.86 Million USD | 55.93% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -76.133% |
Biofrontera Inc. | 10.9 Million USD | 56.096% |
DURECT Corporation | 2.21 Million USD | -115.82% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 93.813% |
Cronos Group Inc. | 30.33 Million USD | 84.215% |
OptiNose, Inc. | 8.05 Million USD | 40.523% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -478905300.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | 15.967% |
Organogenesis Holdings Inc. | 28.25 Million USD | 83.049% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -78.889% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -3.898% |
Radius Health, Inc. | 278.64 Million USD | 98.281% |
Universe Pharmaceuticals INC | 3.34 Million USD | -43.245% |
ProPhase Labs, Inc. | 3.84 Million USD | -24.682% |
Phibro Animal Health Corporation | 265.91 Million USD | 98.199% |
Procaps Group S.A. | 96.83 Million USD | 95.054% |
Alvotech | 74.43 Million USD | 93.566% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.862% |
Rockwell Medical, Inc. | 5.87 Million USD | 18.429% |
Aytu BioPharma, Inc. | 12.63 Million USD | 62.091% |
SIGA Technologies, Inc. | 64.21 Million USD | 92.543% |
Tilray Brands, Inc. | 252.08 Million USD | 98.1% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 88.021% |
Shineco, Inc. | 1.58 Million USD | -201.478% |
PetIQ, Inc. | 159.3 Million USD | 96.994% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 3234.649% |
Incannex Healthcare Limited | -10.01 Million USD | 147.819% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 87.496% |
Alimera Sciences, Inc. | 1.87 Million USD | -154.872% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 87.292% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -197.385% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -6.827% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1782.845% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 53.863% |
Hempacco Co., Inc. | 2.54 Million USD | -88.351% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 93.566% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 89.98% |
Lantheus Holdings, Inc. | 64.02 Million USD | 92.52% |
Currenc Group, Inc. | 732.91 Thousand USD | -553.429% |
Kamada Ltd. | 87.74 Million USD | 94.542% |
Indivior PLC | 141.79 Million USD | 96.623% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -893.91% |
Flora Growth Corp. | 8.5 Million USD | 43.711% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1782.845% |
Evolus, Inc. | 10.99 Million USD | 56.455% |
HUTCHMED (China) Limited | 50.25 Million USD | 90.471% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 95.475% |
Akanda Corp. | 1.28 Million USD | -272.141% |